These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14174233)

  • 1. [OCULAR PRESSURE, NEUROLEPTIC AGENTS AND PARKINSONIAN STATES].
    GEORGIADES G; KYRATSOS C; MICHAILIDES G; TSINOPOULOS T
    Bull Mem Soc Fr Ophtalmol; 1963; 76():340-64. PubMed ID: 14174233
    [No Abstract]   [Full Text] [Related]  

  • 2. [TRIAL SYSTEMATIZATION OF NEUROLEPTIC COMBINATIONS].
    LAMBERT PA
    Encephale; 1964; 53():SUPPL:262-75. PubMed ID: 14161540
    [No Abstract]   [Full Text] [Related]  

  • 3. [COMPLICATIONS OF NEUROLEPTICS].
    NEHLIL J
    Clinique (Paris); 1963 Oct; 58():595-9. PubMed ID: 14092600
    [No Abstract]   [Full Text] [Related]  

  • 4. [COGENTINE (BTMS) IN THE TREATMENT OF NEUROLEPTIC SYNDROMES].
    VOLMAT R; BEAUDOUIN JL; COLLIN J; NICOLAS-CHARLES PJ; ALLERS G
    Encephale; 1964; 53():SUPPL:250-61. PubMed ID: 14161539
    [No Abstract]   [Full Text] [Related]  

  • 5. [EXTRAPYRAMIDAL SYMPTOMS DUE TO THE USE OF PSYCHOPHARMACA].
    BOHACEK N; HAJNSEK F; SARTORIUS N
    Fortschr Neurol Psychiatr Grenzgeb; 1963 Oct; 31():565-70. PubMed ID: 14095902
    [No Abstract]   [Full Text] [Related]  

  • 6. [CLINICAL AND ELECTROMYOGRAPHIC ANALYSIS OF MOTOR DISORDERS IN NEUROLEPTIC THERAPY].
    ZAKRZEWSKA F
    Neurol Neurochir Psychiatr Pol; 1963; 13():679-86. PubMed ID: 14091516
    [No Abstract]   [Full Text] [Related]  

  • 7. [DRUG TREATMENT OF MENTALLY DEFECTIVE CHILDREN].
    BRAUNER F; PRINGUET G
    Rev Neuropsychiatr Infant; 1963; 11():571-82. PubMed ID: 14200156
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE SECONDARY EFFECTS OF NEUROLEPTICS].
    DELAY J; DENIKER P
    Encephale; 1964; 53():SUPPL:103-8. PubMed ID: 14161522
    [No Abstract]   [Full Text] [Related]  

  • 9. [URINARY STEROIDS AND PSYCHOTROPIC CHEMOTHERAPY].
    VALLADE L; CORSETTI R
    Ann Med Psychol (Paris); 1963 Dec; 121():709-20. PubMed ID: 14101917
    [No Abstract]   [Full Text] [Related]  

  • 10. [HUNTINGTON'S CHOREA, HUMOR DISORDERS WITH MANIC MANIFESTATIONS, BENEFICIAL EFFECTS OF HALOPERIDOL (FLUOROPHENYLPIPERIDINOBUTYROPHENONE). ABSENCE OF THE THERAPEUTIC AKINETO-HYPERTONIC SYNDROME].
    NAYRAC P; ARNOTT G; MILBLED G
    Encephale; 1964; 53():SUPPL:221-7. PubMed ID: 14161537
    [No Abstract]   [Full Text] [Related]  

  • 11. [The neuroleptic substances and the behavior of insects. III. Influence on the post-embryonic development of Tribolium confusum Duval (Coleoptera: Tenebrionidae)].
    HUOT L; CORRIVAULT GW; LEBLANC J
    Arch Int Physiol Biochim; 1963 Mar; 71():215-23. PubMed ID: 13955808
    [No Abstract]   [Full Text] [Related]  

  • 12. ELECTROPHYSIOLOGICAL ANALYSIS OF THE NEUROLEPTIC AND ANTIDEPRESSANT ACTIONS OF PSYCHOTROPIC DRUGS IN RABBITS.
    BENESOVA O; BOHDANECKY Z; GROFOVA I
    Int J Neuropharmacol; 1964 Oct; 3():479-88. PubMed ID: 14334609
    [No Abstract]   [Full Text] [Related]  

  • 13. [THE DEMONSTRATION OF PSYCHOTROPIC PHENOTHIAZINE DERIVATIVES AND THEIR EXCRETION PRODUCTS WITH THE AID OF THIN LAYER CHROMATOGRAPHY].
    EBERHARDT H; LERBS OW; FREUNDT KJ
    Arzneimittelforschung; 1963 Sep; 13():804-5. PubMed ID: 14117736
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the cardiovascular effects of haloperidol, thioridazine and chlorpromazine HCl.
    Brannan MD; Riggs JJ; Hageman WE; Pruss TP
    Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):48-57. PubMed ID: 6251766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [EFFECT OF DRUG THERAPY ON REHOSPITALIZATIONS AT THE BEL AIR CLINIC OF PATIENTS WITH CHRONIC PSYCHOSES EXCEPT MANIC-DEPRESSIVE PSYCHOSES].
    FROGEL M
    Psychiatr Neurol (Basel); 1964; 147():267-96. PubMed ID: 14182040
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychomotility and parkinsonism in treatment with neuroleptic drugs.
    FREYHAN FA
    AMA Arch Neurol Psychiatry; 1957 Nov; 78(5):465-72. PubMed ID: 13468837
    [No Abstract]   [Full Text] [Related]  

  • 17. [ON THE ANTAGONISM OF THE ACTION OF NEUROLEPTICS AND ANTIPARKINSON AGENTS].
    ZSCHUCKE CF
    Nervenarzt; 1964 May; 35():217-21. PubMed ID: 14182811
    [No Abstract]   [Full Text] [Related]  

  • 18. Chlorpromazine, methotrimeprazine, and metabolites. Structural changes accompanying the loss of neuroleptic potency by ring sulfoxidation.
    Dahl SG; Hjorth M; Hough E
    Mol Pharmacol; 1982 Mar; 21(2):409-14. PubMed ID: 6124878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular toxic changes associated with chlorpromazine and thioridazine.
    Siddall JR
    Can J Ophthalmol; 1966 Jul; 1(3):190-8. PubMed ID: 5914349
    [No Abstract]   [Full Text] [Related]  

  • 20. Active metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects.
    Dahl SG
    Ther Drug Monit; 1982; 4(1):33-40. PubMed ID: 6122292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.